3e94:A (VAL232) to (ILE442) CRYSTAL STRUCTURE OF RXRALPHA LIGAND BINDING DOMAIN IN COMPLEX WITH TRIBUTYLTIN AND A COACTIVATOR FRAGMENT | PROTEIN-LIGAND COMPLEX, DNA-BINDING, HOST-VIRUS INTERACTION, METAL-BINDING, NUCLEUS, POLYMORPHISM, RECEPTOR, TRANSCRIPTION, TRANSCRIPTION REGULATION, UBL CONJUGATION, ZINC, ZINC-FINGER, ACTIVATOR, PHOSPHOPROTEIN
1nde:A (PRO265) to (ASN478) ESTROGEN RECEPTOR BETA WITH SELECTIVE TRIAZINE MODULATOR | ESTROGEN RECEPTOR, ESTROGEN RECEPTOR BETA, ER, ERB, TRIAZINE, ESTROGEN, ESTRADIOL, OESTROGEN, TRANSCRIPTION
2p1u:A (VAL232) to (GLY443) CRYSTAL STRUCTURE OF THE LIGAND BINDING DOMAIN OF THE RETINOID X RECEPTOR ALPHA IN COMPLEX WITH 3-(2'-ETHOXY)- TETRAHYDRONAPHTYL CINNAMIC ACID AND A FRAGMENT OF THE COACTIVATOR TIF-2 | PROTEIN-LIGAND COMPLEX, HORMONE RECEPTOR
2p1v:A (VAL232) to (GLY443) CRYSTAL STRUCTURE OF THE LIGAND BINDING DOMAIN OF THE RETINOID X RECEPTOR ALPHA IN COMPLEX WITH 3-(2'-PROPOXY)- TETRAHYDRONAPHTYL CINNAMIC ACID AND A FRAGMENT OF THE COACTIVATOR TIF-2 | PROTEIN-LIGAND COMPLEX, HORMONE RECEPTOR
2p7g:A (LYS236) to (GLY442) X-RAY STRUCTURE OF ESTROGEN RELATED RECEPTOR G IN COMPLEX WITH BISPHENOL A. | THREE LAYERED ALPHA HELICAL SANDWICH, HORMONE RECEPTOR
2p7z:A (LYS236) to (LYS439) ESTROGEN RELATED RECEPTOR GAMMA IN COMPLEX WITH 4-HYDROXY- TAMOXIFEN | THREE LAYERED ALPHA HELICAL SANDWICH, HORMONE RECEPTOR
2bj4:A (THR311) to (MET528) ESTROGEN RECEPTOR ALPHA LBD IN COMPLEX WITH A PHAGE-DISPLAY DERIVED PEPTIDE ANTAGONIST | NUCLEAR RECEPTOR, TRANSCRIPTION FACTOR, PEPTIDE ANTAGONIST, LIGAND-BINDING DOMAIN (LBD), DNA-BINDING, NUCLEAR PROTEIN STEROID-BINDING
1bsx:A (THR215) to (GLU445) STRUCTURE AND SPECIFICITY OF NUCLEAR RECEPTOR-COACTIVATOR INTERACTIONS | NUCLEAR RECEPTORS, COACTIVATORS, GRIP1, SPECIFICITY INTERACTION SITE, HORMONE/GROWTH FACTOR COMPLEX
1bsx:B (THR215) to (GLU445) STRUCTURE AND SPECIFICITY OF NUCLEAR RECEPTOR-COACTIVATOR INTERACTIONS | NUCLEAR RECEPTORS, COACTIVATORS, GRIP1, SPECIFICITY INTERACTION SITE, HORMONE/GROWTH FACTOR COMPLEX
3fal:A (VAL232) to (CYS432) HUMANRXR ALPHA & MOUSE LXR ALPHA COMPLEXED WITH RETENOIC ACID AND GSK2186 | NUCLEAR HORMONE RECEPTOR NONSTEROIDAL LXR AGONIST CHOLOESTOROL METABOLISM, DNA-BINDING, HOST-VIRUS INTERACTION, METAL-BINDING, NUCLEUS, POLYMORPHISM, RECEPTOR, TRANSCRIPTION, TRANSCRIPTION REGULATION, UBL CONJUGATION, ZINC, ZINC-FINGER, SIGNALING PROTEIN
3fal:C (VAL232) to (LEU433) HUMANRXR ALPHA & MOUSE LXR ALPHA COMPLEXED WITH RETENOIC ACID AND GSK2186 | NUCLEAR HORMONE RECEPTOR NONSTEROIDAL LXR AGONIST CHOLOESTOROL METABOLISM, DNA-BINDING, HOST-VIRUS INTERACTION, METAL-BINDING, NUCLEUS, POLYMORPHISM, RECEPTOR, TRANSCRIPTION, TRANSCRIPTION REGULATION, UBL CONJUGATION, ZINC, ZINC-FINGER, SIGNALING PROTEIN
3fc6:A (VAL232) to (LEU433) HRXRALPHA & MLXRALPHA WITH AN INDOLE PHARMACOPHORE, SB786875 | LIVER X RECEPTOR, NUCLEAR HORMONE RECEPTORS, AGONISTS, EPOXYCHOLESTEROL, DNA-BINDING, HOST-VIRUS INTERACTION, METAL-BINDING, NUCLEUS, POLYMORPHISM, RECEPTOR, TRANSCRIPTION, TRANSCRIPTION REGULATION, UBL CONJUGATION, ZINC, ZINC-FINGER
3fc6:C (VAL232) to (GLU434) HRXRALPHA & MLXRALPHA WITH AN INDOLE PHARMACOPHORE, SB786875 | LIVER X RECEPTOR, NUCLEAR HORMONE RECEPTORS, AGONISTS, EPOXYCHOLESTEROL, DNA-BINDING, HOST-VIRUS INTERACTION, METAL-BINDING, NUCLEUS, POLYMORPHISM, RECEPTOR, TRANSCRIPTION, TRANSCRIPTION REGULATION, UBL CONJUGATION, ZINC, ZINC-FINGER
1ovl:A (SER363) to (ASP580) CRYSTAL STRUCTURE OF NURR1 LBD | NUUR1, LBD, TRANSCRIPTION
2q6j:B (THR311) to (ASN532) CRYSTAL STRUCTURE OF ESTROGEN RECEPTOR ALPHA COMPLEXED TO A B-N SUBSTITUTED LIGAND | PROTEIN-LIGAND COMPLEX, TRANSCRIPTION
2qab:A (THR311) to (ASN532) CRYSTAL STRUCTURE OF ESTROGEN RECEPTOR ALPHA LIGAND BINDING DOMAIN MUTANT 537S COMPLEXED WITH AN ETHYL INDAZOLE COMPOUND | PROTEIN-LIGAND COMPLEX, TRANSCRIPTION
2qab:B (THR311) to (ASN532) CRYSTAL STRUCTURE OF ESTROGEN RECEPTOR ALPHA LIGAND BINDING DOMAIN MUTANT 537S COMPLEXED WITH AN ETHYL INDAZOLE COMPOUND | PROTEIN-LIGAND COMPLEX, TRANSCRIPTION
2qgt:B (THR311) to (ASN532) CRYSTAL STRUCTURE OF THE ESTROGEN RECEPTOR ALPHA LIGAND BINDING DOMAIN COMPLEXED TO AN ETHER ESTRADIOL COMPOUND | PROTEIN-LIGAND COMPLEX, TRANSCRIPTION
2qgw:A (THR311) to (ASN532) CRYSTAL STRUCTURE OF THE ESTROGEN RECEPTOR ALPHA LIGAND BINDING DOMAIN COMPLEXED WITH A CHLORO-INDAZOLE COMPOUND | PROTEIN-LIGAND COMPLEX, TRANSCRIPTION
2qgw:B (THR311) to (ASN532) CRYSTAL STRUCTURE OF THE ESTROGEN RECEPTOR ALPHA LIGAND BINDING DOMAIN COMPLEXED WITH A CHLORO-INDAZOLE COMPOUND | PROTEIN-LIGAND COMPLEX, TRANSCRIPTION
1dkf:A (PRO236) to (PHE443) CRYSTAL STRUCTURE OF A HETERODIMERIC COMPLEX OF RAR AND RXR LIGAND-BINDING DOMAINS | HELICAL SANDWICH, HETERODIMER, PROTEIN-LIGAND COMPLEX, HORMONE/GROWTH FACTOR RECEPTOR, STRUCTURAL PROTEOMICS IN EUROPE, SPINE, STRUCTURAL GENOMICS
1dkf:B (PRO182) to (ILE402) CRYSTAL STRUCTURE OF A HETERODIMERIC COMPLEX OF RAR AND RXR LIGAND-BINDING DOMAINS | HELICAL SANDWICH, HETERODIMER, PROTEIN-LIGAND COMPLEX, HORMONE/GROWTH FACTOR RECEPTOR, STRUCTURAL PROTEOMICS IN EUROPE, SPINE, STRUCTURAL GENOMICS
4iu7:A (THR311) to (ASN532) CRYSTAL STRUCTURE OF THE ESTROGEN RECEPTOR ALPHA LIGAND-BINDING DOMAIN IN COMPLEX WITH CONSTRAINED WAY-DERIVATIVE, 2B | NUCLEAR HORMONE RECEPTOR, TRANSCRIPTION FACTOR, LIGAND BINDING, NUCLEUS, TRANSCRIPTION
4iv2:A (THR311) to (ASN532) CRYSTAL STRUCTURE OF THE ESTROGEN RECEPTOR ALPHA LIGAND-BINDING DOMAIN IN COMPLEX WITH DYNAMIC WAY-DERIVATIVE, 5A | NUCLEAR HORMONE RECEPTOR, TRANSCRIPTION FACTOR, LIGAND-BINDING, NUCLEUS, TRANSCRIPTION
4iw8:B (THR311) to (LYS531) CRYSTAL STRUCTURE OF THE ESTROGEN RECEPTOR ALPHA LIGAND-BINDING DOMAIN IN COMPLEX WITH DYNAMIC WAY-DERIVATIVE, 9A | NUCLEAR HORMONE RECEPTOR, TRANSCRIPTION FACTOR, LIGAND-BINDING, NUCLEUS, TRANSCRIPTION
1pq6:A (THR221) to (ASP446) HUMAN LXR BETA HORMONE RECEPTOR / GW3965 COMPLEX | LXRB+KB043546/WAY207380/GW3965, TRANSCRIPTION REGULATION
1pq6:D (ALA222) to (LEU444) HUMAN LXR BETA HORMONE RECEPTOR / GW3965 COMPLEX | LXRB+KB043546/WAY207380/GW3965, TRANSCRIPTION REGULATION
1pq9:C (THR221) to (ARG411) HUMAN LXR BETA HORMONE RECEPTOR COMPLEXED WITH T0901317 COMPLEX | LXRB+T0901317 SPLIT, TRANSCRIPTION REGULATION
2qtu:A (PRO265) to (MET479) ESTROGEN RECEPTOR BETA LIGAND-BINDING DOMAIN COMPLEXED TO A BENZOPYRAN LIGAND | NUCLEAR RECEPTOR, LIGAND-BINDING DOMAIN, ALTERNATIVE SPLICING, DNA-BINDING, LIPID-BINDING, METAL-BINDING, NUCLEUS, PHOSPHORYLATION, STEROID-BINDING, TRANSCRIPTION, TRANSCRIPTION REGULATION, ZINC, ZINC-FINGER, TRANSCRIPTION REGULATOR
2qtu:B (SER264) to (MET479) ESTROGEN RECEPTOR BETA LIGAND-BINDING DOMAIN COMPLEXED TO A BENZOPYRAN LIGAND | NUCLEAR RECEPTOR, LIGAND-BINDING DOMAIN, ALTERNATIVE SPLICING, DNA-BINDING, LIPID-BINDING, METAL-BINDING, NUCLEUS, PHOSPHORYLATION, STEROID-BINDING, TRANSCRIPTION, TRANSCRIPTION REGULATION, ZINC, ZINC-FINGER, TRANSCRIPTION REGULATOR
4j24:A (SER264) to (ASN483) ESTROGEN RECEPTOR IN COMPLEX WITH PROLINE-FLANKED LXXLL PEPTIDES | ESTROGEN RECEPTOR, PROLINE, LXXLL, ALPHA-HELIX, STRUCTURE STABILIZATION, HORMONE RECEPTOR-PEPTIDE COMPLEX
4j24:B (PRO265) to (ASN483) ESTROGEN RECEPTOR IN COMPLEX WITH PROLINE-FLANKED LXXLL PEPTIDES | ESTROGEN RECEPTOR, PROLINE, LXXLL, ALPHA-HELIX, STRUCTURE STABILIZATION, HORMONE RECEPTOR-PEPTIDE COMPLEX
4j24:C (SER264) to (ASN483) ESTROGEN RECEPTOR IN COMPLEX WITH PROLINE-FLANKED LXXLL PEPTIDES | ESTROGEN RECEPTOR, PROLINE, LXXLL, ALPHA-HELIX, STRUCTURE STABILIZATION, HORMONE RECEPTOR-PEPTIDE COMPLEX
4j24:D (PRO265) to (ASN483) ESTROGEN RECEPTOR IN COMPLEX WITH PROLINE-FLANKED LXXLL PEPTIDES | ESTROGEN RECEPTOR, PROLINE, LXXLL, ALPHA-HELIX, STRUCTURE STABILIZATION, HORMONE RECEPTOR-PEPTIDE COMPLEX
4j5w:D (GLU233) to (GLY443) CRYSTAL STRUCTURE OF THE APO-PXR/RXRALPHA LBD HETEROTETRAMER COMPLEX | PREGNANE X RECEPTOR, RETINOID X RECEPTOR ALPHA, LIGAND BINDING DOMAIN, NUCLEAR RECEPTOR, ALPHA HELICAL SANDWICH, UNIQUE INTERMOLECULAR BETA-SHEET DIMERIZATION, XENOBIOTIC SENSING, UPREGULATION OF DRUG METABOLISM ENZYMES, RETINOIC ACID-BINDING PROTEIN
4j5x:D (GLU233) to (GLY443) CRYSTAL STRUCTURE OF THE SR12813-BOUND PXR/RXRALPHA LBD HETEROTETRAMER COMPLEX | PREGNANE X RECEPTOR, RETINOID X RECEPTOR ALPHA, LIGAND BINDING DOMAIN, NUCLEAR RECEPTOR, SR12813, ALPHA HELICAL SANDWICH, UNIQUE INTERMOLECULAR BETA-SHEET DIMERIZATION, XENOBIOTIC SENSING, UPREGULATION OF DRUG METABOLISM ENZYMES, RETINOIC ACID-BINDING PROTEIN
3h0a:A (VAL232) to (GLY443) CRYSTAL STRUCTURE OF PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR GAMMA (PPARG) AND RETINOIC ACID RECEPTOR ALPHA (RXRA) IN COMPLEX WITH 9-CIS RETINOIC ACID, CO-ACTIVATOR PEPTIDE, AND A PARTIAL AGONIST | PPAR, TRANSCRIPTION, NUCLEAR RECEPTOR FOLD, TRANSCRIPTION REGULATION, HORMONE, GROWTH FACTOR RECEPTOR, COMPLEX, DNA-BINDING, HOST-VIRUS INTERACTION, ISOPEPTIDE BOND, METAL-BINDING, NUCLEUS, RECEPTOR, ZINC-FINGER, ACTIVATOR, DIABETES MELLITUS, DISEASE MUTATION, OBESITY, PHOSPHOPROTEIN, ACYLTRANSFERASE, PROTO-ONCOGENE, TRANSFERASE
1qkm:A (PRO265) to (MET479) HUMAN OESTROGEN RECEPTOR BETA LIGAND-BINDING DOMAIN IN COMPLEX WITH PARTIAL AGONIST GENISTEIN | NUCLEAR RECEPTOR, TRANSCRIPTION FACTOR, PHYTO-OESTROGEN, PARTIAL AGONIST
2e2r:A (LYS236) to (GLY442) CRYSTAL STRUCTURE OF HUMAN ESTROGEN-RELATED RECEPTOR GAMMA LIGAND BINDING DOMAIN COMPLEX WITH BISPHENOL A | ERR GAMMA, BPA, NUCLEAR RECEPTOR, TRANSCRIPTION
1r1k:A (SER209) to (HIS439) CRYSTAL STRUCTURE OF THE LIGAND-BINDING DOMAINS OF THE HETERODIMER ECR/USP BOUND TO PONASTERONE A | NUCLEAR RECEPTOR, TRANSCRIPTION REGULATION, HETERODIMER, ALPHA-HELICAL SANDWICH, STRUCTURAL PROTEOMICS IN EUROPE, SPINE, STRUCTURAL GENOMICS, HORMONE/GROWTH FACTOR RECEPTOR COMPLEX
1fby:A (VAL232) to (GLY443) CRYSTAL STRUCTURE OF THE HUMAN RXR ALPHA LIGAND BINDING DOMAIN BOUND TO 9-CIS RETINOIC ACID | NUCLEAR RECEPTOR, PROTEIN-LIGAND COMPLEX, RETINOID RECEPTOR, TRANSCRIPTION
1r20:A (SER209) to (HIS439) CRYSTAL STRUCTURE OF THE LIGAND-BINDING DOMAINS OF THE HETERODIMER ECR/USP BOUND TO THE SYNTHETIC AGONIST BYI06830 | NUCLEAR RECEPTOR, HETERODIMER, ALPHA-HELICAL SANDWICH, STRUCTURAL PROTEOMICS IN EUROPE, SPINE, STRUCTURAL GENOMICS, HORMONE/GROWTH FACTOR RECEPTOR COMPLEX
4jyg:A (GLU172) to (PRO396) CRYSTAL STRUCTURE OF RARBETA LBD IN COMPLEX WITH AGONIST BMS411 [4- {[(5,5-DIMETHYL-8-PHENYL-5,6-DIHYDRONAPHTHALEN-2-YL) CARBONYL]AMINO}BENZOIC ACID] | LIGAND BINDING DOMAIN, NUCLEAR HORMONE RECEPTOR, TRANSCRIPTION- AGONIST COMPLEX
4jyh:A (GLU172) to (LYS392) CRYSTAL STRUCTURE OF RARBETA LBD IN COMPLEX WITH SELECTIVE AGONIST BMS948 [4-{[(8-PHENYLNAPHTHALEN-2-YL)CARBONYL]AMINO}BENZOIC ACID] | LIGAND BINDING DOMAIN, NUCLEAR HORMONE RECEPTOR, TRANSCRIPTION- AGONIST COMPLEX
4jyi:B (GLU176) to (ILE395) CRYSTAL STRUCTURE OF RARBETA LBD IN COMPLEX WITH SELECTIVE PARTIAL AGONIST BMS641 [3-CHLORO-4-[(E)-2-(5,5-DIMETHYL-8-PHENYL-5,6- DIHYDRONAPHTHALEN-2-YL)ETHENYL]BENZOIC ACID] | LIGAND BINDING DOMAIN, NUCLEAR HORMONE RECEPTOR, TRANSCRIPTION- AGONIST COMPLEX
1fm9:A (VAL232) to (GLY443) THE 2.1 ANGSTROM RESOLUTION CRYSTAL STRUCTURE OF THE HETERODIMER OF THE HUMAN RXRALPHA AND PPARGAMMA LIGAND BINDING DOMAINS RESPECTIVELY BOUND WITH 9-CIS RETINOIC ACID AND GI262570 AND CO-ACTIVATOR PEPTIDES. | THE HETERODIMER OF THE NUCLEAR RECEPTOR LIGAND BINDING DOMAINS OF RXRALPHA AND PPARGAMMA BOUND RESPECTIVELY WITH 9-CIS RETINOIC ACID AND GI262570 AND CO-ACTIVATOR PEPTIDES, TRANSCRIPTION
2ewp:C (ASN235) to (LYS439) CRYSTAL STRUCTURE OF ESTROGEN RELATED RECEPTOR-3 (ERR-GAMMA) LIGAND BINDING DOMAIND WITH TAMOXIFEN ANALOG GSK5182 | TAMOXIFEN, ERR, ESTROGEN RELATED RECEPTOR, ORPHAN RECEPTOR, TRANSCRIPTION
2ewp:D (ILE237) to (MET419) CRYSTAL STRUCTURE OF ESTROGEN RELATED RECEPTOR-3 (ERR-GAMMA) LIGAND BINDING DOMAIND WITH TAMOXIFEN ANALOG GSK5182 | TAMOXIFEN, ERR, ESTROGEN RELATED RECEPTOR, ORPHAN RECEPTOR, TRANSCRIPTION
2ewp:E (ILE237) to (LYS439) CRYSTAL STRUCTURE OF ESTROGEN RELATED RECEPTOR-3 (ERR-GAMMA) LIGAND BINDING DOMAIND WITH TAMOXIFEN ANALOG GSK5182 | TAMOXIFEN, ERR, ESTROGEN RELATED RECEPTOR, ORPHAN RECEPTOR, TRANSCRIPTION
4k6i:A (VAL232) to (GLY443) CRYSTAL STRUCTURE OF HUMAN RETINOID X RECEPTOR ALPHA-LIGAND BINDING DOMAIN COMPLEX WITH TARGRETIN AND THE COACTIVATOR PEPTIDE GRIP-1 | LIGAND BINDING DOMAIN, CANCER, TARGRETIN (BEXAROTENE), TRANSCRIPTION
1rdt:A (VAL232) to (GLY443) CRYSTAL STRUCTURE OF A NEW REXINOID BOUND TO THE RXRALPHA LIGAND BINDING DOAMIN IN THE RXRALPHA/PPARGAMMA HETERODIMER | HORMONE, RECEPTOR, POLYMORPHISM, HORMONE/GROWTH FACTOR COMPLEX
1g2n:A (ILE210) to (PHE438) CRYSTAL STRUCTURE OF THE LIGAND BINDING DOMAIN OF THE ULTRASPIRACLE PROTEIN USP, THE ORTHOLOG OF RXRS IN INSECTS | ANTIPARALLEL ALPHA-HELICAL SANDWICH, STRUCTURAL PROTEOMICS IN EUROPE, SPINE, STRUCTURAL GENOMICS, GENE REGULATION
1g50:A (THR311) to (ASN532) CRYSTAL STRUCTURE OF A WILD TYPE HER ALPHA LBD AT 2.9 ANGSTROM RESOLUTION | ALPHA HELICES, ESTRADIOL, STRUCTURAL PROTEOMICS IN EUROPE, SPINE, STRUCTURAL GENOMICS, DNA BINDING PROTEIN
3uu7:A (THR311) to (LYS531) CRYSTAL STRUCTURE OF HERA-LBD (Y537S) IN COMPLEX WITH BISPHENOL-A | LIGAND-BINDING DOMAIN OF NUCLEAR HORMONE RECEPTOR, HORMONE RECEPTOR
2fsz:A (PRO265) to (MET479) A SECOND BINDING SITE FOR HYDROXYTAMOXIFEN WITHIN THE COACTIVATOR-BINDING GROOVE OF ESTROGEN RECEPTOR BETA | NUCLEAR HORMONE BINDING DOMAIN, HORMONE/GROWTH FACTOR COMPLEX
2fsz:B (PRO265) to (MET479) A SECOND BINDING SITE FOR HYDROXYTAMOXIFEN WITHIN THE COACTIVATOR-BINDING GROOVE OF ESTROGEN RECEPTOR BETA | NUCLEAR HORMONE BINDING DOMAIN, HORMONE/GROWTH FACTOR COMPLEX
4zi1:A (SER264) to (ASN483) HUMAN ESTROGEN RECEPTOR BETA LIGAND-BINDING DOMAIN IN COMPLEX WITH KB095285 AND CIA12 COACTIVATOR PEPTIDE | ESTROGEN RECEPTOR BETA, BETA SELECTIVE, ERB, SIGNALING PROTEIN
1gwr:B (THR311) to (ASN532) HUMAN OESTROGEN RECEPTOR ALPHA LIGAND-BINDING DOMAIN IN COMPLEX WITH 17BETA-OESTRADIOL AND TIF2 NRBOX3 PEPTIDE | NUCLEAR RECEPTOR, TRANSCRIPTION FACTOR, TRANSACTIVATION, AGONIST, AF2 COACTIVATOR , RECEPTOR, ACTIVATOR, TRANSCRIPTI REGULATION, DNA-BINDING, NUCLEAR PROTEIN, ZINC FINGER, STER BINDING, PHOSPHORYLATION, POLYMORPHISM, ALTERNATIVE SPLICING
4kzi:B (ASN363) to (ASP580) CRYSTAL STRUCTURE OF TR3 LBD IN COMPLEX WITH DPDO | ORPHAN NUCLEAR RECEPTOR, TRANSCRIPTION
2giu:A (PRO265) to (LEU476) HUMAN ESTROGEN RECEPTOR BETA LIGAND-BINDING DOMAIN IN COMPLEX WITH COMPOUND 45 | NUCLEAR RECEPTOR, TRANSCRIPTION FACTOR, ER-BETA, AGONIST, TRANSCRIPTION REGULATOR
4zn9:B (THR311) to (SER527) CRYSTAL STRUCTURE OF THE ER-ALPHA LIGAND-BINDING DOMAIN (Y537S) IN COMPLEX WITH OXABICYCLIC HEPTENE SULFONATE (OBHS) | PROTEIN LIGAND COMPLEX, TRANSCRIPTION
4zns:A (THR311) to (LYS529) CRYSTAL STRUCTURE OF THE ER-ALPHA LIGAND-BINDING DOMAIN (Y537S) IN COMPLEX WITH A 3-FLUORO-SUBSTITUTED OBHS DERIVATIVE | NUCLEAR RECEPTOR, TRANSCRIPTION FACTOR, LIGAND BINDING, PROTEIN- LIGAND COMPLEX, TRANSCRIPTION
2gp7:A (ILE237) to (GLY442) ESTROGEN RELATED RECEPTOR-GAMMA LIGAND BINDING DOMAIN | ESTROGEN RELATED RECEPTOR, ERR, ERRG, ESRRG, NUCLEAR RECEPTOR, STEROID RECEPTOR, TRANSCRIPTION
2gp7:B (ILE237) to (GLY442) ESTROGEN RELATED RECEPTOR-GAMMA LIGAND BINDING DOMAIN | ESTROGEN RELATED RECEPTOR, ERR, ERRG, ESRRG, NUCLEAR RECEPTOR, STEROID RECEPTOR, TRANSCRIPTION
2gp7:C (ILE237) to (GLY442) ESTROGEN RELATED RECEPTOR-GAMMA LIGAND BINDING DOMAIN | ESTROGEN RELATED RECEPTOR, ERR, ERRG, ESRRG, NUCLEAR RECEPTOR, STEROID RECEPTOR, TRANSCRIPTION
1h9u:A (VAL301) to (ILE513) THE STRUCTURE OF THE HUMAN RETINOID-X-RECEPTOR BETA LIGAND BINDING DOMAIN IN COMPLEX WITH THE SPECIFIC SYNTHETIC AGONIST LG100268 | NUCLEAR RECEPTOR, RXR, TRANSCRIPTION FACTOR
1h9u:B (VAL301) to (ILE513) THE STRUCTURE OF THE HUMAN RETINOID-X-RECEPTOR BETA LIGAND BINDING DOMAIN IN COMPLEX WITH THE SPECIFIC SYNTHETIC AGONIST LG100268 | NUCLEAR RECEPTOR, RXR, TRANSCRIPTION FACTOR
1h9u:C (ASP302) to (ILE513) THE STRUCTURE OF THE HUMAN RETINOID-X-RECEPTOR BETA LIGAND BINDING DOMAIN IN COMPLEX WITH THE SPECIFIC SYNTHETIC AGONIST LG100268 | NUCLEAR RECEPTOR, RXR, TRANSCRIPTION FACTOR
1h9u:D (VAL301) to (ILE513) THE STRUCTURE OF THE HUMAN RETINOID-X-RECEPTOR BETA LIGAND BINDING DOMAIN IN COMPLEX WITH THE SPECIFIC SYNTHETIC AGONIST LG100268 | NUCLEAR RECEPTOR, RXR, TRANSCRIPTION FACTOR
4zsh:A (VAL232) to (LEU441) RXR LBD IN COMPLEX WITH 9-CIS-13,14-DIHYDRORETINOIC ACID | TRANSCRIPTION, NUCLEAR RECEPTOR, RXR
3ips:A (SER207) to (ASP432) X-RAY STRUCTURE OF BENZISOXAZOLE SYNTHETIC AGONIST BOUND TO THE LXR- ALPHA | NUCLEAR RECEPTOR, LXR HOMODIMER, LXR SIGNALING, ALTERNATIVE SPLICING, NUCLEUS, POLYMORPHISM, RECEPTOR, TRANSCRIPTION, TRANSCRIPTION REGULATION, ACTIVATOR, ISOPEPTIDE BOND, PROTO-ONCOGENE, CHOLESTEROL, ABCA1, HETERODIMER, RXR, LIGAND COMPLEX
1hj1:A (SER219) to (MET434) RAT OESTROGEN RECEPTOR BETA LIGAND-BINDING DOMAIN IN COMPLEX WITH PURE ANTIOESTROGEN ICI164,384 | NUCLEAR RECEPTOR, TRANSCRIPTION FACTOR, OESTROGEN, ANTAGONIST
1u3q:A (PRO265) to (ASN483) CRYSTAL STRUCTURE OF ESTROGEN RECEPTOR BETA COMPLEXED WITH CL-272 | ESTROGEN RECEPTOR, ESTROGEN RECEPTOR BETA, ER-BETA, ER, ESTROGEN, NUCLEAR RECEPTOR, TRANSCRIPTION FACTOR, AGONIST
1u3q:B (SER264) to (LYS482) CRYSTAL STRUCTURE OF ESTROGEN RECEPTOR BETA COMPLEXED WITH CL-272 | ESTROGEN RECEPTOR, ESTROGEN RECEPTOR BETA, ER-BETA, ER, ESTROGEN, NUCLEAR RECEPTOR, TRANSCRIPTION FACTOR, AGONIST
1u3q:C (SER264) to (ASN483) CRYSTAL STRUCTURE OF ESTROGEN RECEPTOR BETA COMPLEXED WITH CL-272 | ESTROGEN RECEPTOR, ESTROGEN RECEPTOR BETA, ER-BETA, ER, ESTROGEN, NUCLEAR RECEPTOR, TRANSCRIPTION FACTOR, AGONIST
1u3q:D (SER264) to (ASN483) CRYSTAL STRUCTURE OF ESTROGEN RECEPTOR BETA COMPLEXED WITH CL-272 | ESTROGEN RECEPTOR, ESTROGEN RECEPTOR BETA, ER-BETA, ER, ESTROGEN, NUCLEAR RECEPTOR, TRANSCRIPTION FACTOR, AGONIST
1u3r:A (SER264) to (ASN483) CRYSTAL STRUCTURE OF ESTROGEN RECEPTOR BETA COMPLEXED WITH WAY-338 | ESTROGEN RECEPTOR, ESTROGEN RECEPTOR BETA, ER-BETA, ER, ESTROGEN, NUCLEAR RECEPTOR, TRANSCRIPTION FACTOR, AGONIST
1u3r:B (SER264) to (ASN483) CRYSTAL STRUCTURE OF ESTROGEN RECEPTOR BETA COMPLEXED WITH WAY-338 | ESTROGEN RECEPTOR, ESTROGEN RECEPTOR BETA, ER-BETA, ER, ESTROGEN, NUCLEAR RECEPTOR, TRANSCRIPTION FACTOR, AGONIST
1u9e:A (SER264) to (ASN483) CRYSTAL STRUCTURE OF ESTROGEN RECEPTOR BETA COMPLEXED WITH WAY-397 | ESTROGEN RECEPTOR, ESTROGEN RECEPTOR BETA, ER-BETA, ER, ESTROGEN, NUCLEAR RECEPTOR, TRANSCRIPTION FACTOR, AGONIST
1u9e:B (SER264) to (ASN483) CRYSTAL STRUCTURE OF ESTROGEN RECEPTOR BETA COMPLEXED WITH WAY-397 | ESTROGEN RECEPTOR, ESTROGEN RECEPTOR BETA, ER-BETA, ER, ESTROGEN, NUCLEAR RECEPTOR, TRANSCRIPTION FACTOR, AGONIST
2i0g:A (PRO265) to (MET479) BENZOPYRANS ARE SELECTIVE ESTROGEN RECEPTOR BETA AGONISTS (SERBAS) WITH NOVEL ACTIVITY IN MODELS OF BENIGN PROSTATIC HYPERPLASIA | NUCLEAR RECEPTOR, LIGAND BINDING DOMAIN, TRANSCRIPTION
2i0g:B (SER264) to (MET479) BENZOPYRANS ARE SELECTIVE ESTROGEN RECEPTOR BETA AGONISTS (SERBAS) WITH NOVEL ACTIVITY IN MODELS OF BENIGN PROSTATIC HYPERPLASIA | NUCLEAR RECEPTOR, LIGAND BINDING DOMAIN, TRANSCRIPTION
1uhl:A (VAL301) to (GLY514) CRYSTAL STRUCTURE OF THE LXRALFA-RXRBETA LBD HETERODIMER | LIGAND-BINDING DOMAIN, DNA BINDING PROTEIN
4m8e:A (VAL232) to (GLY443) CRYSTAL STRUCTURE OF HUMAN RETINOID X RECEPTOR ALPHA-LIGAND BINDING DOMAIN COMPLEX WITH (S) 4-METHYL 9CUAB30 COACTIVATOR PEPTIDE GRIP-1 | ANTIPARALLEL SANDWICH, LIGAND BINDING, COACTIVATOR BINDING, DIMERIZATION, ACTIVATION FUNCTION, TRANSCRIPTION, NUCLEAR RECEPTORS, LIGAND BINDING DOMIAN, LIGAND BINDING POCKET, COACTIVATOR BINDING SITE, CANCER, 4-METHYL 9CUAB30 ((2E,4E,6Z,8E)-8-[(4'S)METHYL-3',4'- DIHYDRO-1'(2'H)-NAPHTHALEN-1'-YLIDENE]-3,7-DIMETHYL-2,4,6- OCTATRIENOIC ACID)
4mga:B (THR311) to (ASN532) CRYSTAL STRUCTURE OF HERA-LBD (Y537S) IN COMPLEX WITH 4-TERT- OCTYLPHENOL | LIGAND-BINDING DOMAIN OF NUCLEAR HORMONE RECEPTOR, HORMONE RECEPTOR
2j7y:A (SER219) to (ASN438) STRUCTURE OF 17-EPIESTRIOL-BOUND ESTROGEN RECEPTOR BETA LBD IN COMPLEX WITH LXXLL MOTIF FROM NCOA5 | RECEPTOR, ACTIVATOR, REPRESSOR, ZINC-FINGER, NUCLEAR RECEPTOR, TRANSCRIPTION FACTOR, NUCLEAR PROTEIN, PHOSPHORYLATION, STEROID-BINDING, COACTIVATOR, COREPRESSOR, DNA-BINDING, GLYCOPROTEIN, TRANSCRIPTION REGULATION, TRANSCRIPTION, METAL-BINDING, LIPID-BINDING
4n1y:A (GLN248) to (GLY458) CRYSTAL STRUCTURE OF THE PACIFIC OYSTER ESTROGEN RECEPTOR LIGAND BINDING DOMAIN | ESTROGEN, NUCLEAR HORMONE RECEPTOR, ENDOCRINE SIGNALING, TRANSCRIPTION
4n1y:B (GLN248) to (GLY458) CRYSTAL STRUCTURE OF THE PACIFIC OYSTER ESTROGEN RECEPTOR LIGAND BINDING DOMAIN | ESTROGEN, NUCLEAR HORMONE RECEPTOR, ENDOCRINE SIGNALING, TRANSCRIPTION
1k74:A (VAL232) to (GLY443) THE 2.3 ANGSTROM RESOLUTION CRYSTAL STRUCTURE OF THE HETERODIMER OF THE HUMAN PPARGAMMA AND RXRALPHA LIGAND BINDING DOMAINS RESPECTIVELY BOUND WITH GW409544 AND 9-CIS RETINOIC ACID AND CO-ACTIVATOR PEPTIDES. | THE HETERODIMER OF THE NUCLEAR RECEPTOR LIGAND BINDING DOMAINS OF RXRALPHA AND PPARGAMMA BOUND RESPECTIVELY WITH 9-CIS RETINOIC ACID AND GW409544 AND COACTIVATOR PEPTIDES, TRANSCRIPTION
1x7b:B (SER264) to (ASN483) CRYSTAL STRUCTURE OF ESTROGEN RECEPTOR BETA COMPLEXED WITH ERB-041 | ESTROGEN RECEPTOR, ESTROGEN RECEPTOR BETA, ER-BETA, ER, ESTROGEN, NUCLEAR RECEPTOR, TRANSCRIPTION FACTOR, AGONIST
1x78:A (PRO265) to (ASN483) CRYSTAL STRUCTURE OF ESTROGEN RECEPTOR BETA COMPLEXED WITH WAY-244 | ESTROGEN RECEPTOR, ESTROGEN RECEPTOR BETA, ER-BETA, ER, ESTROGEN, NUCLEAR RECEPTOR, TRANSCRIPTION FACTOR, AGONIST
1x78:B (PRO265) to (ASN483) CRYSTAL STRUCTURE OF ESTROGEN RECEPTOR BETA COMPLEXED WITH WAY-244 | ESTROGEN RECEPTOR, ESTROGEN RECEPTOR BETA, ER-BETA, ER, ESTROGEN, NUCLEAR RECEPTOR, TRANSCRIPTION FACTOR, AGONIST
1x7e:B (THR311) to (ASN532) CRYSTAL STRUCTURE OF ESTROGEN RECEPTOR ALPHA COMPLEXED WITH WAY-244 | ESTROGEN RECEPTOR, ESTROGEN RECEPTOR BETA, ER-BETA, ER, ESTROGEN RECEPTOR ALPHA, ER-ALPHA, ESTROGEN, NUCLEAR RECEPT TRANSCRIPTION FACTOR, AGONIST
1l2j:A (PRO265) to (LEU476) HUMAN ESTROGEN RECEPTOR BETA LIGAND-BINDING DOMAIN IN COMPLEX WITH (R, R)-5,11-CIS-DIETHYL-5,6,11,12-TETRAHYDROCHRYSENE-2,8-DIOL | NUCLEAR RECEPTOR, TRANSCRIPTION FACTOR, ESTROGEN, ANTAGONIST, TRANSCRIPTION RECEPTOR
1l2j:B (PRO265) to (MET479) HUMAN ESTROGEN RECEPTOR BETA LIGAND-BINDING DOMAIN IN COMPLEX WITH (R, R)-5,11-CIS-DIETHYL-5,6,11,12-TETRAHYDROCHRYSENE-2,8-DIOL | NUCLEAR RECEPTOR, TRANSCRIPTION FACTOR, ESTROGEN, ANTAGONIST, TRANSCRIPTION RECEPTOR
3jzc:A (THR215) to (GLU445) CRYSTAL STRUCTURE OF TR-BETA BOUND TO THE SELECTIVE THYROMIMETIC TRIAC | TR, TRIAC, ENTROPY, DEAFNESS, DISEASE MUTATION, DNA-BINDING, METAL- BINDING, NUCLEUS, RECEPTOR, TRANSCRIPTION, TRANSCRIPTION REGULATION, ZINC-FINGER
4oc7:A (VAL232) to (GLY443) RETINOIC ACID RECEPTOR ALPHA IN COMPLEX WITH (E)-3-(3'-ALLYL-6- HYDROXY-[1,1'-BIPHENYL]-3-YL)ACRYLIC ACID AND A FRAGMENT OF THE COACTIVATOR TIF2 | LIGAND BINDING DOMAIN, TRANSCRIPTION
2nxx:E (SER333) to (ASN532) CRYSTAL STRUCTURE OF THE LIGAND-BINDING DOMAINS OF THE T.CASTANEUM (COLEOPTERA) HETERODIMER ECRUSP BOUND TO PONASTERONE A | HORMONE RECEPTOR, APO AND HOLO LIGAND BINDING POCKET, HORMONE/GROWTH FACTOR COMPLEX
2nxx:F (SER333) to (ASN532) CRYSTAL STRUCTURE OF THE LIGAND-BINDING DOMAINS OF THE T.CASTANEUM (COLEOPTERA) HETERODIMER ECRUSP BOUND TO PONASTERONE A | HORMONE RECEPTOR, APO AND HOLO LIGAND BINDING POCKET, HORMONE/GROWTH FACTOR COMPLEX
2nxx:G (SER333) to (ASN532) CRYSTAL STRUCTURE OF THE LIGAND-BINDING DOMAINS OF THE T.CASTANEUM (COLEOPTERA) HETERODIMER ECRUSP BOUND TO PONASTERONE A | HORMONE RECEPTOR, APO AND HOLO LIGAND BINDING POCKET, HORMONE/GROWTH FACTOR COMPLEX
2nxx:H (SER333) to (ASN532) CRYSTAL STRUCTURE OF THE LIGAND-BINDING DOMAINS OF THE T.CASTANEUM (COLEOPTERA) HETERODIMER ECRUSP BOUND TO PONASTERONE A | HORMONE RECEPTOR, APO AND HOLO LIGAND BINDING POCKET, HORMONE/GROWTH FACTOR COMPLEX
2z4b:A (PRO265) to (MET479) ESTROGEN RECEPTOR BETA LIGAND-BINDING DOMAIN COMPLEXED TO A BENZOPYRAN LIGAND | NUCLEAR RECEPTOR LIGAND BINDING DOMAIN, TRANSCRIPTION
2z4b:B (SER264) to (MET479) ESTROGEN RECEPTOR BETA LIGAND-BINDING DOMAIN COMPLEXED TO A BENZOPYRAN LIGAND | NUCLEAR RECEPTOR LIGAND BINDING DOMAIN, TRANSCRIPTION
1xiu:A (VAL214) to (ASP418) CRYSTAL STRUCTURE OF THE AGONIST-BOUND LIGAND-BINDING DOMAIN OF BIOMPHALARIA GLABRATA RXR | NUCLEAR RECEPTOR, PROTEIN-LIGAND COMPLEX, RETINOID RECEPTOR, TRANSCRIPTION-TRANSFERASE COMPLEX
1xiu:B (VAL214) to (GLY417) CRYSTAL STRUCTURE OF THE AGONIST-BOUND LIGAND-BINDING DOMAIN OF BIOMPHALARIA GLABRATA RXR | NUCLEAR RECEPTOR, PROTEIN-LIGAND COMPLEX, RETINOID RECEPTOR, TRANSCRIPTION-TRANSFERASE COMPLEX
2zas:A (LYS236) to (GLY442) CRYSTAL STRUCTURE OF HUMAN ESTROGEN-RELATED RECEPTOR GAMMA LIGAND BINDING DOMAIN COMPLEX WITH 4-ALPHA-CUMYLPHENOL, A BISPHENOL A DERIVATIVE | ERR GAMMA, BPA, 4-ALPHA-CUMYLPHENOL, NUCLEAR RECEPTOR, TRANSCRIPTION, ACTIVATOR, DNA-BINDING, METAL-BINDING, NUCLEUS, TRANSCRIPTION REGULATION, ZINC-FINGER
2zkc:A (LYS236) to (GLY442) CRYSTAL STRUCTURE OF HUMAN ESTROGEN-RELATED RECEPTOR GAMMA LIGAND BINDING DOMAIN COMPLEX WITH BISPHENOL Z | ERR GAMMA, BPA, NUCLEAR RECEPTOR, TRANSCRIPTION, ACTIVATOR, DNA- BINDING, METAL-BINDING, NUCLEUS, TRANSCRIPTION REGULATION, ZINC- FINGER
1xv9:A (VAL232) to (ILE442) CRYSTAL STRUCTURE OF CAR/RXR HETERODIMER BOUND WITH SRC1 PEPTIDE, FATTY ACID, AND 5B-PREGNANE-3,20-DIONE. | CAR, RXR, SRC1, PREGNANEDIONE, DNA BINDING PROTEIN
2zxz:A (VAL232) to (GLY443) CRYSTAL STRUCTURE OF THE HUMAN RXR ALPHA LIGAND BINDING DOMAIN BOUND TO A SYNTHETIC AGONIST COMPOUND AND A COACTIVATOR PEPTIDE | TRANSCRIPTION REGULATION, NUCLEAR RECEPTOR, STRUCTURAL GENOMICS, STRUCTURAL GENOMICS CONSORTIUM FOR RESEARCH ON GENE EXPRESSION, SGCGES
2zy0:A (VAL232) to (GLY443) CRYSTAL STRUCTURE OF THE HUMAN RXR ALPHA LIGAND BINDING DOMAIN BOUND TO A SYNTHETIC AGONIST COMPOUND AND A COACTIVATOR PEPTIDE | TRANSCRIPTION REGULATION, NUCLEAR RECEPTOR, STRUCTURAL GENOMICS, STRUCTURAL GENOMICS CONSORTIUM FOR RESEARCH ON GENE EXPRESSION, SGCGES
2zy0:C (VAL232) to (GLY443) CRYSTAL STRUCTURE OF THE HUMAN RXR ALPHA LIGAND BINDING DOMAIN BOUND TO A SYNTHETIC AGONIST COMPOUND AND A COACTIVATOR PEPTIDE | TRANSCRIPTION REGULATION, NUCLEAR RECEPTOR, STRUCTURAL GENOMICS, STRUCTURAL GENOMICS CONSORTIUM FOR RESEARCH ON GENE EXPRESSION, SGCGES
3kmr:A (PRO182) to (GLU401) CRYSTAL STRUCTURE OF RARALPHA LIGAND BINDING DOMAIN IN COMPLEX WITH AN AGONIST LIGAND (AM580) AND A COACTIVATOR FRAGMENT | NUCLEAR RECEPTOR TRANSCRIPTION FACTOR LIGAND BINDING DOMAIN, DNA- BINDING, METAL-BINDING, NUCLEUS, PHOSPHOPROTEIN, PROTO-ONCOGENE, RECEPTOR, TRANSCRIPTION, TRANSCRIPTION REGULATION, ZINC-FINGER, ACTIVATOR, ACYLTRANSFERASE, ISOPEPTIDE BOND, TRANSFERASE
1mv9:A (VAL232) to (GLY443) CRYSTAL STRUCTURE OF THE HUMAN RXR ALPHA LIGAND BINDING DOMAIN BOUND TO THE EICOSANOID DHA (DOCOSA HEXAENOIC ACID) AND A COACTIVATOR PEPTIDE | TRANSCRIPTION REGULATION, NUCLEAR PROTEIN
1mzn:C (VAL1232) to (ILE1442) CRYSTAL STRUCTURE AT 1.9 ANGSTROEMS RESOLUTION OF THE HOMODIMER OF HUMAN RXR ALPHA LIGAND BINDING DOMAIN BOUND TO THE SYNTHETIC AGONIST COMPOUND BMS 649 AND A COACTIVATOR PEPTIDE | TRANSCRIPTION, NUCLEAR RECEPTOR, RETINOIC ACID RECEPTORS, AGONIST
1mzn:G (VAL3232) to (LEU3441) CRYSTAL STRUCTURE AT 1.9 ANGSTROEMS RESOLUTION OF THE HOMODIMER OF HUMAN RXR ALPHA LIGAND BINDING DOMAIN BOUND TO THE SYNTHETIC AGONIST COMPOUND BMS 649 AND A COACTIVATOR PEPTIDE | TRANSCRIPTION, NUCLEAR RECEPTOR, RETINOIC ACID RECEPTORS, AGONIST
5die:A (THR311) to (ASN532) CRYSTAL STRUCTURE OF THE ER-ALPHA LIGAND-BINDING DOMAIN IN COMPLEX WITH A TRIFLUORO-SUBSTITUTED A-CD RING ESTROGEN DERIVATIVE (1S,3AR, 5S,7AS)-7A-METHYL-5-(2,3,5-TRIFLUORO-4-HYDROXYPHENYL)OCTAHYDRO-1H- INDEN-1-OL | NUCLEAR RECEPTOR, TRANSCRIPTION FACTOR, LIGAND BINDING, PROTEIN- LIGAND COMPLEX, TRANSCRIPTION
5dmf:B (THR311) to (LYS531) CRYSTAL STRUCTURE OF THE ER-ALPHA LIGAND-BINDING DOMAIN IN COMPLEX WITH A 4-FLUOROPHENYLAMINO-SUBSTITUTED, METHYL TRIARYL-ETHYLENE DERIVATIVE 4,4'-(2-{3-[(4-FLUOROPHENYL)AMINO]PHENYL}PROP-1-ENE-1,1- DIYL)DIPHENOL | NUCLEAR RECEPTOR, TRANSCRIPTION FACTOR, LIGAND BINDING, PROTEIN- LIGAND COMPLEX, TRANSCRIPTION
4poh:A (VAL232) to (GLY443) CRYSTAL STRUCTURE OF HUMAN RETINOID X RECEPTOR ALPHA-LIGAND BINDING DOMAIN COMPLEX WITH 8-METHYL UAB30 AND THE COACTIVATOR PEPTIDE GRIP-1 | LIGAND BINDING DOMAIN, NUCLEAR RECEPTOR, CANCER, METHYL SUBSTITUTED REXINOID, 8-METHYL UAB30, TRANSCRIPTION
4poj:A (VAL232) to (GLY443) CRYSTAL STRUCTURE OF HUMAN RETINOID X RECEPTOR ALPHA-LIGAND BINDING DOMAIN COMPLEX WITH 7-METHYL UAB30 AND THE COACTIVATOR PEPTIDE GRIP-1 | LIGAND BINDING DOMAIN, NUCLEAR RECEPTOR, CANCER, LIPID TOXICITY, REXINOID, 7-METHYL UAB30, TRANSCRIPTION
4pp3:A (VAL232) to (LEU441) CRYSTAL STRUCTURE OF HUMAN RETINOID X RECEPTOR ALPHA-LIGAND BINDING DOMAIN COMPLEX WITH 6-METHYL UAB30 AND THE COACTIVATOR PEPTIDE GRIP-1 | LIGAND BINDING DOMAIN, 6-METHYL UAB30, REXINOID, CANCER, LIPID TOXICITY, TRANSCRIPTION
4pp5:A (VAL232) to (GLY443) CRYSTAL STRUCTURE OF HUMAN RETINOID X RECEPTOR ALPHA-LIGAND BINDING DOMAIN COMPLEX WITH 5-METHYL UAB30 AND THE COACTIVATOR PEPTIDE GRIP-1 | LIGAND BINDING DOMAIN. 6-METHYL UAB30, REXINOID, CANCER, LIPID TOXICITY, LIGAND BINDING DOMAIN, 6-METHYL UAB30, TRANSCRIPTION
4pp6:A (THR311) to (ASN532) CRYSTAL STRUCTURE OF THE ESTROGEN RECEPTOR ALPHA LIGAND-BINDING DOMAIN IN COMPLEX WITH RESVERATROL | NUCLEAR HORMONE RECEPTOR, TRANSCRIPTION FACTOR, LIGAND BINDING, NUCLEUS, PROTEIN BINDING
1zaf:A (SER264) to (ASN483) CRYSTAL STRUCTURE OF ESTROGEN RECEPTOR BETA COMPLEXED WITH 3-BROMO-6-HYDROXY-2-(4-HYDROXY-PHENYL)-INDEN-1-ONE | ESTROGEN RECEPTOR, ESTROGEN RECEPTOR BETA, ER-BETA, ER, ESTROGEN, NUCLEAR RECEPTOR, TRANSCRIPTION FACTOR, AGONIST, TRANSCRIPTION/TRANSFERASE COMPLEX
1zaf:B (PRO265) to (ASN483) CRYSTAL STRUCTURE OF ESTROGEN RECEPTOR BETA COMPLEXED WITH 3-BROMO-6-HYDROXY-2-(4-HYDROXY-PHENYL)-INDEN-1-ONE | ESTROGEN RECEPTOR, ESTROGEN RECEPTOR BETA, ER-BETA, ER, ESTROGEN, NUCLEAR RECEPTOR, TRANSCRIPTION FACTOR, AGONIST, TRANSCRIPTION/TRANSFERASE COMPLEX
5dtv:A (THR311) to (ASN532) CRYSTAL STRUCTURE OF THE ER-ALPHA LIGAND-BINDING DOMAIN IN COMPLEX WITH A DIMETHYL-SUBSTITUTED, 3,4-DIARYLTHIOPHENE DIOXIDE CORE LIGAND | NUCLEAR RECEPTOR, TRANSCRIPTION FACTOR, LIGAND BINDING, PROTEIN- LIGAND COMPLEX, TRANSCRIPTION
5du5:A (THR311) to (ASN532) CRYSTAL STRUCTURE OF THE ER-ALPHA LIGAND-BINDING DOMAIN IN COMPLEX WITH A DICHLORO-SUBSTITUTED, 3,4-DIARYLTHIOPHENE DIOXIDE CORE LIGAND | NUCLEAR RECEPTOR, TRANSCRIPTION FACTOR, LIGAND BINDING, PROTEIN- LIGAND COMPLEX, TRANSCRIPTION
5dwg:A (ALA312) to (ASN532) CRYSTAL STRUCTURE OF THE ER-ALPHA LIGAND-BINDING DOMAIN IN COMPLEX WITH THE TRIARYL-SUBSTITUTED IMINE ANALOG, 4-{(E)-(4-HYDROXYPHENYL) [(2-METHYLPHENYL)IMINO]METHYL}BENZENE-1,3-DIOL | NUCLEAR RECEPTOR, TRANSCRIPTION FACTOR, LIGAND BINDING, PROTEIN- LIGAND COMPLEX, TRANSCRIPTION
5dxm:B (THR311) to (LYS531) CRYSTAL STRUCTURE OF THE ER-ALPHA LIGAND-BINDING DOMAIN IN COMPLEX WITH THE CYCLOFENIL DERIVATIVE 3-[(E)-(1S,5S)-BICYCLO[3.3.1]NON-9- YLIDENE(4-HYDROXYPHENYL)METHYL]PHENOL | NUCLEAR RECEPTOR, TRANSCRIPTION FACTOR, LIGAND BINDING, PROTEIN- LIGAND COMPLEX, TRANSCRIPTION
5dyd:A (ALA312) to (LYS531) CRYSTAL STRUCTURE OF THE ER-ALPHA LIGAND-BINDING DOMAIN IN COMPLEX WITH THE CYCLOFENIL DERIVATIVE 4,4'-{[(3S)-3-(METHYLSULFANYL) CYCLOHEXYLIDENE]METHANEDIYL}DIPHENOL | NUCLEAR RECEPTOR, TRANSCRIPTION FACTOR, LIGAND BINDING, PROTEIN- LIGAND COMPLEX, TRANSCRIPTION
4q50:C (THR311) to (TYR526) THE ESTROGEN RECEPTOR ALPHA LIGAND BINDING DOMAIN D538G MUTANT IN COMPLEX WITH 4-HYDROXYTAMOXIFEN | ACQUIRED SERM-RESISTANCE, BREAST CANCER, ACTIVATING MUTATION, SERM-ER STRUCTURE, ALPHA HELIX, NUCLEAR HORMONE RECEPTOR, HORMONE BINDING PROTEIN
5e19:A (THR311) to (ASN532) CRYSTAL STRUCTURE OF THE ER-ALPHA LIGAND-BINDING DOMAIN IN COMPLEX WITH THE CYCLOFENIL DERIVATIVE METHYL {4-[BIS(4-HYDROXYPHENYL) METHYLIDENE]CYCLOHEXYL}ACETATE | NUCLEAR RECEPTOR, TRANSCRIPTION FACTOR, LIGAND BINDING, PROTEIN- LIGAND COMPLEX, TRANSCRIPTION
5ei1:A (THR311) to (ASN532) CRYSTAL STRUCTURE OF THE ER-ALPHA LIGAND-BINDING DOMAIN (Y537S) IN COMPLEX WITH THE IMIDAZOPYRIDINE DERIVATIVE 2-(4-HYDROXYPHENYL)-3- IODANYL-IMIDAZO[1,2-A]PYRIDIN-6-OL | NUCLEAR RECEPTOR, TRANSCRIPTION FACTOR, LIGAND BINDING, PROTEIN- LIGAND COMPLEX, TRANSCRIPTION
5ei1:B (THR311) to (ASN532) CRYSTAL STRUCTURE OF THE ER-ALPHA LIGAND-BINDING DOMAIN (Y537S) IN COMPLEX WITH THE IMIDAZOPYRIDINE DERIVATIVE 2-(4-HYDROXYPHENYL)-3- IODANYL-IMIDAZO[1,2-A]PYRIDIN-6-OL | NUCLEAR RECEPTOR, TRANSCRIPTION FACTOR, LIGAND BINDING, PROTEIN- LIGAND COMPLEX, TRANSCRIPTION
2acl:A (VAL232) to (GLU434) LIVER X-RECEPTOR ALPHA LIGAND BINDING DOMAIN WITH SB313987 | NUCLEAR HORMONE RECEPTOR LIGAND BINDING DOMAIN TRANSCRIPTION FACTOR THREE LAYERED A-HELIX FOLD
2acl:C (VAL232) to (GLU434) LIVER X-RECEPTOR ALPHA LIGAND BINDING DOMAIN WITH SB313987 | NUCLEAR HORMONE RECEPTOR LIGAND BINDING DOMAIN TRANSCRIPTION FACTOR THREE LAYERED A-HELIX FOLD
2acl:E (VAL232) to (GLU434) LIVER X-RECEPTOR ALPHA LIGAND BINDING DOMAIN WITH SB313987 | NUCLEAR HORMONE RECEPTOR LIGAND BINDING DOMAIN TRANSCRIPTION FACTOR THREE LAYERED A-HELIX FOLD
2acl:H (PHE227) to (ASP430) LIVER X-RECEPTOR ALPHA LIGAND BINDING DOMAIN WITH SB313987 | NUCLEAR HORMONE RECEPTOR LIGAND BINDING DOMAIN TRANSCRIPTION FACTOR THREE LAYERED A-HELIX FOLD
5eit:A (THR311) to (ASN532) CRYSTAL STRUCTURE OF THE ER-ALPHA LIGAND-BINDING DOMAIN (Y537S) IN COMPLEX WITH THE IMIDAZOPYRIDINE DERIVATIVE 2-(4-HYDROXYPHENYL)-3- (TRIFLUOROMETHYL)IMIDAZO[1,2-A]PYRIDIN-6-OL | NUCLEAR RECEPTOR, TRANSCRIPTION FACTOR, LIGAND BINDING, PROTEIN- LIGAND COMPLEX, TRANSCRIPTION
5eit:B (THR311) to (ASN532) CRYSTAL STRUCTURE OF THE ER-ALPHA LIGAND-BINDING DOMAIN (Y537S) IN COMPLEX WITH THE IMIDAZOPYRIDINE DERIVATIVE 2-(4-HYDROXYPHENYL)-3- (TRIFLUOROMETHYL)IMIDAZO[1,2-A]PYRIDIN-6-OL | NUCLEAR RECEPTOR, TRANSCRIPTION FACTOR, LIGAND BINDING, PROTEIN- LIGAND COMPLEX, TRANSCRIPTION
4ree:B (ALA31) to (ASP249) CRYSTAL STRUCTURE OF TR3 LBD IN COMPLEX WITH MOLECULE 6 | LBD, TRANSCRIPTION
4rfw:A (VAL232) to (ILE442) CRYSTAL STRUCTURE OF HUMAN RETINOID X RECEPTOR ALPHA-LIGAND BINDING DOMAIN COMPLEX WITH 9CUAB70 AND THE COACTIVATOR PEPTIDE GRIP-1 | LIGAND BINDING DOMAIN, CANCER PREVENTION, COACTIVATOR PEPTIDE, CONFORMATIONALLY CONSTRAINED RETINOIDS, TRANSCRIPTION
4rmc:A (VAL232) to (LEU420) CRYSTAL STRUCTURE OF HUMAN RETINOID X RECEPTOR ALPHA-LIGAND BINDING DOMAIN COMPLEX WITH 9CUAB76 AND THE COACTIVATOR PEPTIDE GRIP-1 | LIGAND BINDING DOMAIN, CANCER PREVENTION, TRANSCRIPTION
4rmd:A (VAL232) to (LEU441) CRYSTAL STRUCTURE OF HUMAN RETINOID X RECEPTOR ALPHA LIGAND BINDING DOMAIN COMPLEX WITH 9CUAB110 AND COACTIVATOR PEPTIDE GRIP-1 | CANCER PREVENTION, LIGAND BINDING DOMAIN, TRANSCRIPTION
3oap:A (VAL232) to (LEU420) CRYSTAL STRUCTURE OF HUMAN RETINOID X RECEPTOR ALPHA-LIGAND BINDING DOMAIN COMPLEX WITH 9-CIS RETINOIC ACID AND THE COACTIVATOR PEPTIDE GRIP-1 | ANTIPARALLEL SANDWICH, LIGAND BINDING, COACTIVATOR BINDING, DIMERIZATION, ACTIVATION FUNCTION, TRANSCRIPTION
3oll:A (PRO265) to (ASN483) CRYSTAL STRUCTURE OF PHOSPHORYLATED ESTROGEN RECEPTOR BETA LIGAND BINDING DOMAIN | STEROID BINDING, PHOSPHORYLATION, HORMONE RECEPTOR-ACTIVATOR COMPLEX
3oll:B (PRO265) to (ASN483) CRYSTAL STRUCTURE OF PHOSPHORYLATED ESTROGEN RECEPTOR BETA LIGAND BINDING DOMAIN | STEROID BINDING, PHOSPHORYLATION, HORMONE RECEPTOR-ACTIVATOR COMPLEX
3omo:A (PRO265) to (ASN483) FRAGMENT-BASED DESIGN OF NOVEL ESTROGEN RECEPTOR LIGANDS | STEROID BINDING, PROTEIN BINDING
3omo:B (PRO265) to (ASN483) FRAGMENT-BASED DESIGN OF NOVEL ESTROGEN RECEPTOR LIGANDS | STEROID BINDING, PROTEIN BINDING
3omp:A (PRO265) to (ASN483) FRAGMENT-BASED DESIGN OF NOVEL ESTROGEN RECEPTOR LIGANDS | STEROID BINDING, PROTEIN BINDING
3omp:B (PRO265) to (ASN483) FRAGMENT-BASED DESIGN OF NOVEL ESTROGEN RECEPTOR LIGANDS | STEROID BINDING, PROTEIN BINDING
3omq:A (PRO265) to (ASN483) FRAGMENT-BASED DESIGN OF NOVEL ESTROGEN RECEPTOR LIGANDS | STEROID BINDING, PROTEIN BINDING
3omq:B (PRO265) to (ASN483) FRAGMENT-BASED DESIGN OF NOVEL ESTROGEN RECEPTOR LIGANDS | STEROID BINDING, PROTEIN BINDING
3ozj:A (VAL232) to (GLY443) CRYSTAL STRUCTURE OF HUMAN RETINOIC X RECEPTOR ALPHA COMPLEXED WITH BIGELOVIN AND COACTIVATOR SRC-1 | NUCLEAR RECEPTOR LIGAND-BINDING DOMAIN, LIGAND-BINDING AND TRANSACTIVATION, TRANSCRIPTION
3ozj:C (GLU233) to (GLY443) CRYSTAL STRUCTURE OF HUMAN RETINOIC X RECEPTOR ALPHA COMPLEXED WITH BIGELOVIN AND COACTIVATOR SRC-1 | NUCLEAR RECEPTOR LIGAND-BINDING DOMAIN, LIGAND-BINDING AND TRANSACTIVATION, TRANSCRIPTION
5hjp:C (VAL301) to (GLY514) IDENTIFICATION OF LXRBETA SELECTIVE AGONISTS FOR THE TREATMENT OF ALZHEIMER'S DISEASE | AGONIST, ALZHEIMER'S, SIGNALING PROTEIN
4dk7:A (THR221) to (ASP446) CRYSTAL STRUCTURE OF LXR LIGAND BINDING DOMAIN IN COMPLEX WITH FULL AGONIST 1 | LIGAND BINDING DOMAIN, NUCLEAR HORMONE RECEPTOR, TRANSCRIPTION- PEPTIDE-AGONIST COMPLEX
4dk8:A (THR221) to (ASP446) CRYSTAL STRUCTURE OF LXR LIGAND BINDING DOMAIN IN COMPLEX WITH PARTIAL AGONIST 5 | LIGAND BINDING DOMAIN, NUCLEAR HORMONE RECEPTOR, TRANSCRIPTION- PEPTIDE-AGONIST COMPLEX
5hjs:A (SER43) to (ASP268) IDENTIFICATION OF LXRBETA SELECTIVE AGONISTS FOR THE TREATMENT OF ALZHEIMER'S DISEASE | AGONIST, ALZHEIMER'S, SIGNALING PROTEIN
4dm8:B (TYR1180) to (ILE1404) CRYSTAL STRUCTURE OF RARB LBD IN COMPLEX WITH 9CIS RETINOIC ACID | NUCLEAR RECEPTOR, RARB, 9CIS RETINOIC ACID, ALPHA HELICAL SANDWICH, TRANSCRIPTION FACTOR, RETINOIC ACID, TRANSCRIPTION-PROTEIN BINDING COMPLEX
5hyr:A (THR311) to (ASN532) ESTROGEN RECEPTOR ALPHA LIGAND BINDING DOMAIN Y537S MUTANT IN COMPLEX WITH STAPLED PEPTIDE SRC2-SP2 AND ESTRADIOL | BREAST CANCER, ESTROGEN RECEPTOR, SYNTHETIC PEPTIDE, STAPLED PEPTIDE, ENDOCRINE, HORMONE, GENE REGULATION
5i4v:B (VAL301) to (ILE513) DISCOVERY OF NOVEL, ORALLY EFFICACIOUS LIVER X RECEPTOR (LXR) BETA AGONISTS | LXRBETA-LBD, RXRBETA-LBD, HETERODIMER, AGONIST, DNA BINDING PROTEIN
5i4v:F (VAL301) to (ILE513) DISCOVERY OF NOVEL, ORALLY EFFICACIOUS LIVER X RECEPTOR (LXR) BETA AGONISTS | LXRBETA-LBD, RXRBETA-LBD, HETERODIMER, AGONIST, DNA BINDING PROTEIN
3q95:A (THR311) to (ASN532) CRYSTAL STRUCTURE OF HUMAN ESTROGEN RECEPTOR ALPHA LBD IN COMPLEX WITH GRIP PEPTIDE AND ESTRIOL | TRANSCRIPTIONAL REGULATOR, NUCLEAR RECEPTOR, TRANSCRIPTION REGULATOR
3r5m:A (ASN227) to (ILE442) CRYSTAL STRUCTURE OF RXRALPHALBD COMPLEXED WITH THE AGONIST MAGNOLOL | NUCLEAR RECEPTOR, TRANSCRIPTION FACTOR, TRANSCRIPTION-TRANSCRIPTION AGONIST COMPLEX
5jy3:B (ALA222) to (GLN445) CRYSTAL STRUCTURE OF LXRBETA (NUCLEAR RECEPTOR SUBFAMILY 1, GROUP H, MEMBER 2) COMPLEXED WITH BMS-852927 | NHR, NR1H2, LXR-B, LXRB, UNR, NER-I, RIP15, NER, TRANSCRIPTION
5jy3:D (THR221) to (GLN445) CRYSTAL STRUCTURE OF LXRBETA (NUCLEAR RECEPTOR SUBFAMILY 1, GROUP H, MEMBER 2) COMPLEXED WITH BMS-852927 | NHR, NR1H2, LXR-B, LXRB, UNR, NER-I, RIP15, NER, TRANSCRIPTION
5kcc:B (ALA312) to (LYS529) CRYSTAL STRUCTURE OF THE ER-ALPHA LIGAND-BINDING DOMAIN (Y537S) IN COMPLEX WITH OXABICYCLIC HEPTENE SULFONAMIDE (OBHS-N) | NUCLEAR RECEPTOR, TRANSCRIPTION FACTOR, LIGAND BINDING, PROTEIN- LIGAND COMPLEX, TRANSCRIPTION
5kct:A (THR311) to (ASN532) CRYSTAL STRUCTURE OF THE ER-ALPHA LIGAND-BINDING DOMAIN (Y537S) IN COMPLEX WITH AN N-ETHYL, 4-CHLOROBENZYL OBHS-N DERIVATIVE | NUCLEAR RECEPTOR, TRANSCRIPTION FACTOR, LIGAND BINDING, PROTEIN- LIGAND COMPLEX, TRANSCRIPTION
5kyj:B (VAL301) to (LEU512) BRAIN PENETRANT LIVER X RECEPTOR (LXR) MODULATORS BASED ON A 2,4,5,6- TETRAHYDROPYRROLO[3,4-C]PYRAZOLE CORE | DNA BINDING PROTEIN, NUCLEAR RECEPTORS, LIVER X RECEPTOR, RETINOIC ACID X RECEPTOR, LXRBETA-LBD/RXRBETA-LBD HETERODIMER, CHEMICAL MODULATORS
5kyj:F (VAL301) to (ILE513) BRAIN PENETRANT LIVER X RECEPTOR (LXR) MODULATORS BASED ON A 2,4,5,6- TETRAHYDROPYRROLO[3,4-C]PYRAZOLE CORE | DNA BINDING PROTEIN, NUCLEAR RECEPTORS, LIVER X RECEPTOR, RETINOIC ACID X RECEPTOR, LXRBETA-LBD/RXRBETA-LBD HETERODIMER, CHEMICAL MODULATORS
1a52:B (THR311) to (LYS531) ESTROGEN RECEPTOR ALPHA LIGAND-BINDING DOMAIN COMPLEXED TO ESTRADIOL | RECEPTOR, ESTROGEN, LIGAND, TRANSCRIPTION REGULATION
4whg:B (ASN32) to (ASP249) CRYSTAL STRUCTURE OF TR3 LBD IN COMPLEX WITH MOLECULE 3 | LBD, TRANSCRIPTION
2p1t:A (VAL232) to (GLY443) CRYSTAL STRUCTURE OF THE LIGAND BINDING DOMAIN OF THE RETINOID X RECEPTOR ALPHA IN COMPLEX WITH 3-(2'-METHOXY)- TETRAHYDRONAPHTYL CINNAMIC ACID AND A FRAGMENT OF THE COACTIVATOR TIF-2 | PROTEIN-LIGAND COMPLEX, HORMONE RECEPTOR
3fug:A (VAL232) to (GLY443) CRYSTAL STRUCTURE OF THE RETINOID X RECEPTOR LIGAND BINDING DOMAIN BOUND TO THE SYNTHETIC AGONIST 3-[4-HYDROXY-3-(3,5, 5,8,8-PENTAMETHYL-5,6,7,8-TETRAHYDRONAPHTHALEN-2-YL)- PHENYL]ACRYLIC ACID | PROTEIN-LIGAND COMPLEX, HORMONE RECEPTOR, DNA-BINDING, HOST- VIRUS INTERACTION, METAL-BINDING, NUCLEUS, POLYMORPHISM, RECEPTOR, TRANSCRIPTION, TRANSCRIPTION REGULATION, UBL CONJUGATION, ZINC, ZINC-FINGER, ACTIVATOR, PHOSPHOPROTEIN, TRANSCRIPTION/TRANSCRIPTION REGULATOR COMPLEX
2q70:A (THR311) to (MET528) ESTROGEN RECEPTOR ALPHA LIGAND-BINDING DOMAIN COMPLXED TO A BENZOPYRAN LIGAND | TRANSCRIPTION FACTOR, ESTROGEN RECEPTOR
1pqc:C (ALA222) to (ASP446) HUMAN LXR BETA HORMONE RECEPTOR COMPLEXED WITH T0901317 | LXRB+T0901317, TRANSCRIPTION REGULATION
1pqc:D (THR221) to (ARG443) HUMAN LXR BETA HORMONE RECEPTOR COMPLEXED WITH T0901317 | LXRB+T0901317, TRANSCRIPTION REGULATION
4j26:A (PRO265) to (ASN483) ESTROGEN RECEPTOR IN COMPLEX WITH PROLINE-FLANKED LXXLL PEPTIDES | ESTROGEN RECEPTOR, PROLINE, LXXLL, ALPHA-HELIX, STRUCTURE STABILIZATION, HORMONE RECEPTOR-PEPTIDE COMPLEX
4j26:B (PRO265) to (ASN483) ESTROGEN RECEPTOR IN COMPLEX WITH PROLINE-FLANKED LXXLL PEPTIDES | ESTROGEN RECEPTOR, PROLINE, LXXLL, ALPHA-HELIX, STRUCTURE STABILIZATION, HORMONE RECEPTOR-PEPTIDE COMPLEX
4k4j:A (VAL232) to (GLY443) CRYSTAL STRUCTURE OF HUMAN RETINOID X RECEPTOR ALPHA-LIGAND BINDING DOMAIN COMPLEX WITH 9CUAB30 AND THE COACTIVATOR PEPTIDE GRIP-1 | LIGAND BINDING DOMAIN, CANCER, 9-CIS-UAB30, TRANSCRIPTION
4znu:B (THR311) to (MET528) CRYSTAL STRUCTURE OF THE ER-ALPHA LIGAND-BINDING DOMAIN (Y537S) IN COMPLEX WITH A 2-METHYL-SUBSTITUTED OBHS DERIVATIVE | NUCLEAR RECEPTOR, TRANSCRIPTION FACTOR, LIGAND BINDING, PROTEIN- LIGAND COMPLEX, TRANSCRIPTION
1u3s:A (PRO265) to (ASN483) CRYSTAL STRUCTURE OF ESTROGEN RECEPTOR BETA COMPLEXED WITH WAY-797 | ESTROGEN RECEPTOR, ESTROGEN RECEPTOR BETA, ER-BETA, ER, ESTROGEN, NUCLEAR RECEPTOR, TRANSCRIPTION FACTOR, AGONIST
1u3s:B (PRO265) to (ASN483) CRYSTAL STRUCTURE OF ESTROGEN RECEPTOR BETA COMPLEXED WITH WAY-797 | ESTROGEN RECEPTOR, ESTROGEN RECEPTOR BETA, ER-BETA, ER, ESTROGEN, NUCLEAR RECEPTOR, TRANSCRIPTION FACTOR, AGONIST
1uom:A (PRO336) to (LEU525) THE STRUCTURE OF ESTROGEN RECEPTOR IN COMPLEX WITH A SELECTIVE AND POTENT TETRAHYDROISOCHIOLIN LIGAND. | SELECTIVE ESTROGEN RECEPTOR MODULATORS, SERM, RECEPTOR, TRANSCRIPTION REGULATION, DNA-BINDING, NUCLEAR PROTEIN, ZINC-FINGER, STEROID-BINDING, PHOSPHORYLATION, POLYMORPHISM 3D-STRUCTURE, ALTERNATIVE SPLICING
2jj3:A (PRO265) to (MET479) ESTROGEN RECEPTOR BETA LIGAND BINDING DOMAIN IN COMPLEX WITH A BENZOPYRAN AGONIST | PHOSPHORYLATION, STEROID-BINDING, NUCLEAR RECEPTOR, TRANSCRIPTION REGULATION, ALTERNATIVE SPLICING, LIGAND BINDING DOMAIN, ZINC, NUCLEUS, RECEPTOR, ZINC-FINGER, DNA-BINDING, TRANSCRIPTION, METAL-BINDING, LIPID-BINDING
2jj3:B (SER264) to (MET479) ESTROGEN RECEPTOR BETA LIGAND BINDING DOMAIN IN COMPLEX WITH A BENZOPYRAN AGONIST | PHOSPHORYLATION, STEROID-BINDING, NUCLEAR RECEPTOR, TRANSCRIPTION REGULATION, ALTERNATIVE SPLICING, LIGAND BINDING DOMAIN, ZINC, NUCLEUS, RECEPTOR, ZINC-FINGER, DNA-BINDING, TRANSCRIPTION, METAL-BINDING, LIPID-BINDING
1x76:B (PRO265) to (ASN483) CRYSTAL STRUCTURE OF ESTROGEN RECEPTOR BETA COMPLEXED WITH WAY-697 | ESTROGEN RECEPTOR, ESTROGEN RECEPTOR BETA, ER-BETA, ER, ESTROGEN, NUCLEAR RECEPTOR, TRANSCRIPTION FACTOR, AGONIST
1x7j:A (SER264) to (ASN483) CRYSTAL STRUCTURE OF ESTROGEN RECEPTOR BETA COMPLEXED WITH GENISTEIN | ESTROGEN RECEPTOR, ESTROGEN RECEPTOR BETA, ER-BETA, ER, ESTROGEN, NUCLEAR RECEPTOR, TRANSCRIPTION FACTOR, AGONIST
1x7j:B (SER264) to (ASN483) CRYSTAL STRUCTURE OF ESTROGEN RECEPTOR BETA COMPLEXED WITH GENISTEIN | ESTROGEN RECEPTOR, ESTROGEN RECEPTOR BETA, ER-BETA, ER, ESTROGEN, NUCLEAR RECEPTOR, TRANSCRIPTION FACTOR, AGONIST
1xdk:A (ALA231) to (GLY448) CRYSTAL STRUCTURE OF THE RARBETA/RXRALPHA LIGAND BINDING DOMAIN HETERODIMER IN COMPLEX WITH 9-CIS RETINOIC ACID AND A FRAGMENT OF THE TRAP220 COACTIVATOR | NUCLEAR RECEPTOR, COACTIVATOR, LIGAND, HORMONE-GROWTH FACTOR RECEPTOR COMPLEX
1xdk:E (ALA231) to (GLY448) CRYSTAL STRUCTURE OF THE RARBETA/RXRALPHA LIGAND BINDING DOMAIN HETERODIMER IN COMPLEX WITH 9-CIS RETINOIC ACID AND A FRAGMENT OF THE TRAP220 COACTIVATOR | NUCLEAR RECEPTOR, COACTIVATOR, LIGAND, HORMONE-GROWTH FACTOR RECEPTOR COMPLEX
2yly:B (PRO265) to (MET479) SULFONAMIDES AS SELECTIVE ESTROGEN RECEPTOR BETA AGONISTS. | RECEPTOR
1mvc:A (VAL232) to (GLY443) CRYSTAL STRUCTURE OF THE HUMAN RXR ALPHA LIGAND BINDING DOMAIN BOUND TO THE SYNTHETIC AGONIST COMPOUND BMS 649 AND A COACTIVATOR PEPTIDE | NUCLEAR RECEPTOR, RETINOIC ACID, AGONIST RECOGNITION, TRANSCRIPTION FACTOR
3kwy:A (VAL232) to (GLY443) CRYSTAL STRUCTURE OF RXRALPHA LIGAND BINDING DOMAIN IN COMPLEX WITH TRIPHENYLTIN AND A COACTIVATOR FRAGMENT | NUCLEAR RECEPTOR TRANSCRIPTION ORGANOTIN, DNA-BINDING, HOST-VIRUS INTERACTION, ISOPEPTIDE BOND, METAL-BINDING, NUCLEUS, RECEPTOR, TRANSCRIPTION, TRANSCRIPTION REGULATION, ZINC-FINGER, ACTIVATOR, PHOSPHOPROTEIN
5dkb:B (THR311) to (ASN532) CRYSTAL STRUCTURE OF THE ER-ALPHA LIGAND-BINDING DOMAIN IN COMPLEX WITH A 3-METHYLPHENYLAMINO-SUBSTITUTED ETHYL TRIARYL-ETHYLENE DERIVATIVE 4,4'-(2-{3-[(3-METHYLPHENYL)AMINO]PHENYL}BUT-1-ENE-1,1- DIYL)DIPHENOL | NUCLEAR RECEPTOR, TRANSCRIPTION FACTOR, LIGAND BINDING, PROTEIN- LIGAND COMPLEX, TRANSCRIPTION
1yy4:A (SER264) to (ASN483) CRYSTAL STRUCTURE OF ESTROGEN RECEPTOR BETA COMPLEXED WITH 1-CHLORO-6-(4-HYDROXY-PHENYL)-NAPHTHALEN-2-OL | ESTROGEN RECEPTOR, ESTROGEN RECEPTOR BETA, ER-BETA, ER, ESTROGEN, NUCLEAR RECEPTOR, TRANSCRIPTION FACTOR, AGONIST
1yy4:B (SER264) to (ASN483) CRYSTAL STRUCTURE OF ESTROGEN RECEPTOR BETA COMPLEXED WITH 1-CHLORO-6-(4-HYDROXY-PHENYL)-NAPHTHALEN-2-OL | ESTROGEN RECEPTOR, ESTROGEN RECEPTOR BETA, ER-BETA, ER, ESTROGEN, NUCLEAR RECEPTOR, TRANSCRIPTION FACTOR, AGONIST
1yye:B (SER264) to (LYS482) CRYSTAL STRUCTURE OF ESTROGEN RECEPTOR BETA COMPLEXED WITH WAY-202196 | ESTROGEN RECEPTOR, ESTROGEN RECEPTOR BETA, ER-BETA, ER, ESTROGEN, NUCLEAR RECEPTOR, TRANSCRIPTION FACTOR, AGONIST
5dx3:B (THR311) to (ASN532) ESTROGEN RECEPTOR ALPHA LIGAND BINDING DOMAIN Y537S MUTANT IN COMPLEX WITH STAPLED PEPTIDE SRC2-P3 AND ESTRADIOL | SYNTHETIC PEPTIDE, STAPLED PEPTIDE, ESTROGEN RECEPTOR ALPHA, SOMATIC MUTATION, PEPTIDE MIMETIC, AF-2 BINDING, HORMONE RECEPTOR-PEPTIDE COMPLEX
5egv:B (THR311) to (ASN532) CRYSTAL STRUCTURE OF THE ER-ALPHA LIGAND-BINDING DOMAIN (Y537S) IN COMPLEX THE 3,4-DIARYL-FURAN DERIVATIVE 3-CHLORANYL-4-[4-(2- CHLORANYL-4-OXIDANYL-PHENYL)FURAN-3-YL]PHENOL | NUCLEAR RECEPTOR, TRANSCRIPTION FACTOR, LIGAND BINDING, PROTEIN- LIGAND COMPLEX, TRANSCRIPTION
4rme:A (VAL232) to (LEU420) CRYSTAL STRUCTURE OF HUMAN RETINOID X RECEPTOR ALPHA LIGAND BINDING DOMAIN COMPLEX WITH 9CUAB111 AND COACTIVATOR PEPTIDE GRIP-1 | LIGAND BINDING DOMAIN, CANCER PREVENTION, TRANSCRIPTION
3ols:A (PRO265) to (ASN483) CRYSTAL STRUCTURE OF ESTROGEN RECEPTOR BETA LIGAND BINDING DOMAIN | STEROID BINDING, HORMONE RECEPTOR-ACTIVATOR COMPLEX
3ols:B (PRO265) to (ASN483) CRYSTAL STRUCTURE OF ESTROGEN RECEPTOR BETA LIGAND BINDING DOMAIN | STEROID BINDING, HORMONE RECEPTOR-ACTIVATOR COMPLEX
4dm6:B (TYR1180) to (ILE1404) CRYSTAL STRUCTURE OF RARB LBD HOMODIMER IN COMPLEX WITH TTNPB | TRANSCRIPTION, NUCLEAR RECEPTOR, RETINOIC ACID, ALPHA HELICAL SANDWICH, TRANSCRIPTION REGULATOR, RETINOIC ACID BINDING, NUCLEUS - CYTOPLASM, TRANSCRIPTION-PROTEIN BINDING COMPLEX
5kya:B (VAL301) to (ILE513) BRAIN PENETRANT LIVER X RECEPTOR (LXR) MODULATORS BASED ON A 2,4,5,6- TETRAHYDROPYRROLO[3,4-C]PYRAZOLE CORE | NUCLEAR RECEPTOR, LIVER X RECEPTOR, LXRBETA-LBD/RXRBETA-LBD HETERODIMER, CHEMICAL MODULATORS, DNA BINDING PROTEIN
5kya:F (VAL301) to (ILE513) BRAIN PENETRANT LIVER X RECEPTOR (LXR) MODULATORS BASED ON A 2,4,5,6- TETRAHYDROPYRROLO[3,4-C]PYRAZOLE CORE | NUCLEAR RECEPTOR, LIVER X RECEPTOR, LXRBETA-LBD/RXRBETA-LBD HETERODIMER, CHEMICAL MODULATORS, DNA BINDING PROTEIN